Lymphoblastic lymphoma: A clinicopathologic study of 95 patients
Bharat N. Nathwani(City Of Hope National Medical Center), Henry Rappaport(City Of Hope National Medical Center), Lawrence W. Diamond, Robert M. Bearman(City Of Hope National Medical Center), Hun Kim, Nis I. Nissen, Carl D. Winberg, Richard A. Gams(Breast Center), John H. Glick(University of Pennsylvania), Stephen E. Jones(Cleveland Clinic)
Cited by 175
Related Papers
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
|Journal of Clinical Oncology|1997|652
A common progenitor for human myeloid and lymphoid cells
|Nature|1978|277
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
|Journal of Clinical Oncology|1997|269
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.
|Journal of Clinical Oncology|1993|193